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Patients with raised platelet counts can have pseu-
dohyperkalaemia – this can be differentiated by
measuring plasma instead or serum potassium
concentration.
Case report
A 99-year-old woman was admitted following a
mechanical fall. The patient suffered from fre-
quent falls averaging around six falls per year.
On this occasion the patient explained that she
had simply lost her balance and denied any
further symptoms. The patient’s past medical
history was signiﬁcant for essential thrombo-
cythaemia diagnosed 10 years earlier which was
initially managed with hydroxycarbamide and
followed up via outpatient haematology clinics.
In addition to this the patient also had a history
of macular degeneration, carpal tunnel syndrome
and cognitive impairment. Blood tests on admis-
sion showed a platelet count of 1836 with a potass-
ium concentration of 5.9 mmol/L. Repeat blood
tests following admission demonstrated platelet
count now of 2348 with a subsequent rise in pot-
assium level to 6.9 mmol/L. There were curiously
no ECG changes of hyperkalaemia and the rest of
the blood results, including renal function and
inﬂammatory markers were normal. Nonetheless
the patient was infused with insulin and dextrose
which brought the potassium level to 5.6 mmol/L.
However the potassium level was difﬁcult to
control and continued to consistently rise
beyond 6 mmol/L. The patient was subsequently
repeatedly treated with insulin and dextrose infu-
sions to lower the potassium level several times.
After exhausting the causes of high serum potass-
ium levels a plasma potassium was requested
from the laboratory. The result returned as
3.0 mmol/L. The patient was in fact hypokalaemic
secondary to repeated insulin dextrose infusions.
The diagnosis of pseudohyperkalaemia due to
thrombocythaemia was made and only plasma
potassium levels were recorded subsequently.
Discussion
Potassium is the most common cation in the body
and 98% of it is located intracellularly.
1 Daily
intake is about 1.5 mmol/kg and serum levels
are usually strictly homeostatically maintained
between 3.5 and 5 mmol/L. Its elimination is
chieﬂy by the kidneys, and hence renal disease
and acute tubular acidosis is commonly respon-
sible for hyperkalaemia by reduced excretion.
Medications (notably NSAIDS and potassium
sparring diuretics) and adrenocortical insufﬁ-
ciency are well recorded causes of hyperkalaemia.
Innate hormones which affect potassium levels
include adrenaline and insulin;
1 both lower its
levels with the latter being used in the emergency
therapy of hyperkalaemia.
Pseudohyperkalaemia can be deﬁned as a
serum potassium concentration 0.4 mmol/L
greater than the plasma concentration.
2 The obser-
vation of pseudohyperkalaemia in thrombocytosis
was published as early as 1955.
1 It was noted that
high values of serum potassium were obtained in
the absence of other electrolyte abnormalities in
patients with high platelet counts. It is due to the
degranulation of platelets when clotting in vitro,
releasing potassium and calcium into the serum.
3–5
Additionally, since platelets have the smallest par-
ticle size, they become positioned near the top of
the blood tube forming a buffy layer. As a result
they are aspirated into the sampling machine
preferentially if there is a low quantity of the
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1specimen. This is a common laboratory erroneous
source of hyperkalaemia. A higher platelet count
would be expected to proportionally increase
recorded potassium levels but this does not
occur, probably due to uptake by other cell types
(white cells and erythrocytes).
6
Thrombocytosis will be discussed in this report
but it is not the only cause of spurious hyperkalae-
mia; other cell types such as erythrocytes and leu-
cocytes also give rise to this phenomenon. Hence
when assessing leukaemia patients, particular
attention should be paid to the time between vene-
puncture and laboratory plasma separation as any
delay will result in a raised serum potassium due
to cell degradation.
7,8 Patients with mixed cell
type disorders such as polycythaemia vera have
more pronounced hyperkalaemia.
9 In addition
to this, certain general practical considerations
during venepuncture for electrolyte specimens
from all patients with or without disease can
avoid spurious results. Pearls of wisdom passed
down generations of junior doctors such as
asking patients to repeatedly clench a hand
under tourniquet hand to make veins more
visible could raise potassium levels markedly.
10
Leaving a tourniquet on the arm for too long is a
well-recognized cause of abnormally high potass-
ium levels as is a tourniquet which is too tight.
Clinically the diagnosis of pseudohyperkalae-
mia is difﬁcult to make. The absence of any ECG
changes in the presence of dangerously high pot-
assium levels is a favourable indicator of the diag-
nosis.
11 This case report will discuss spurious
hyperkalaemia due to thrombocythaemia.
There are many causes of secondary thrombo-
cythaemia ranging from infection (by virtue of
platelets being acute phase reactants),
12 cancer,
bleeding and even in patients following splenect-
omy.
13 Essential thrombocythaemia is identiﬁed
by increased platelet counts (normal 150–450 ×
10
9/L) from abnormal pluripotent stem cell pro-
liferation resulting in excessive megakaryocyte
division. The clinical complications involve the
sequelae of abnormal platelet function, namely
haemorrhage or thrombosis.
Clinical presentation is often as a result of
micro or macro thrombosis as well as bleeding.
This can range from myocardial infarction and
stroke to headaches and digital occlusion and
gangrene.Bleeding,especiallyfromthegastrointes-
tinal tract can occur. On clinical examination,
hepatomegaly and splenomegaly may be appreci-
ated. The diagnosis is clinched with full blood
count investigations revealing thrombocytosis.
Furtherbonemarrowbiopsymayshowgiantmega-
karyocytes with megakaryocytic hyperplasia.
Electrolytes may show pseudohyperkalaemia
as described above. A rise of between 0.07–
0.15 mmol/L of potassium can be extrapolated
for every 100 × 10(9)/L increase in platelet
count
14 with as much as 0.7 mmol/L in the
serum K+ concentration from large (1000 × 10
(9)/L) increases in platelet count
15 depending on
the analysing technique used. The mainstay of
treatment involves lowering the platelet count in
order to prevent the life-threatening complications
described above. The management of choice
involves hydroxycarbamide and aspirin treat-
ment.
16 The resulting pseudohyperkalaemia
requires no further treatment, only acute recog-
nition. Although the hyperkalaemia in this case
report was spurious in nature, the patient was
treated due to ignorance of this phenomenon.
The urgency of treatment was to avoid the well-
known complications of true hyperkalaemia
which will be brieﬂy discussed below alongside
urgent management.
The main complications of untreated hyperka-
laemia are its impact on the myocardium. Classic
characteristic changes of hyperkalaemia on
electrocardiogram include tall ‘tented’ T-waves,
widened QRS complexes, ﬂattened P-waves, pro-
longed PR interval progressing to life-threatening
arrhythmias such as ventricular tachycardia, ven-
tricular ﬁbrillation or asystole. Howevercharacter-
istic ECG ﬁndings alone cannot objectively be
used to extrapolate potassium levels and often
do not lead to early treatment.
17 It was on this
basis that the patient in this case was treated
despite the absence of ECG changes on sequential
ECGs. Hyperkalaemia has few clinical symptoms,
thus contributing to its danger. These could
include non-speciﬁc symptoms such as fatigue,
paresthesias, confusion and muscle weakness.
17
Thetreatment of hyperkalaemiadepends on the
level of potassium and its cause. Mild hyperkalae-
mia can be managed by treating the underlying
cause, e.g. renal failure. However, potassium con-
centrations of above 6, ora lower level with electro-
cardiogram changes of hyperkalaemia (described
above) shouldbetreated immediately.Theﬁrst pri-
ority is to stabilize the myocardium with 10 mL of
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210% calcium gluconate slow IV infusion over
5 min. Then the potassium can be shifted into the
intracellular compartment with 10 units of
insulin with 50 mL of 50% dextrose. The steady
maintenance of potassium levels can be instigated
with 15 g of oral polystyrene sulphonate resin
(calcium resonium) orally four times a day to
remove potassiumfrom thebodyover theproceed-
ing few days. All potassium-retaining medication
should be stopped and potassium concentration
should be checked twice daily in these patients.
However, in this case due to the repeated
treatment of spurious pseudohyperkalaemia, the
patient was iatrogenically made hypokalaemic.
Severe hypokalaemia is also a medical emergency.
Mild hypokalaemia is often asymptomatic and
can be corrected with oral supplementation.
However, with more severe cases the patient can
present with polyuria or nocturia, abdominal
cramps, paresthesias, skeletal muscle weakness,
paralysis, palpitations and psychological symp-
toms. ECG changes can show the presence of U
waves, prolonged QT interval, ﬂattened T waves
and ST depression. The condition can be life-
threatening when the patient develops cardiac
arrhythmias and it can lead to ventricular tachy-
cardia or ventricular ﬁbrillation. The treatment is
to correct the potassium level immediately. This
may require intensive care input and the insertion
of a central line to allow rapid replenishment.
The association with essential thrombocythae-
mia and pseudohyperkalaemia has been docu-
mented for many years yet it is still not widely
appreciated by many clinicians. Normal electro-
lytes values are derived from serum levels. In
this case the degranulation of platelets was spur-
iously altering serum potassium levels. It was
only when plasma potassium levels were obtained
that the true level of potassium was revealed and
how the patient had been mistreated prior to
this. Figure 1 shows the comparison between the
platelet counts in this patient and their respective
serum and plasma potassium levels.
Conclusion
Hyperkalaemia is a commonly encountered emer-
gency managed on a daily basis on medical wards.
This article has discussed the potential causes of
hyperkalaemia and described the signiﬁcance of
excluding haematological conditions such as
thrombocythaemia before initiating treatment.
Spurious hyperkalaemia due to essential throm-
bocythaemia is well-documented but poorly
recognized among doctors. This case report is
not the ﬁrst time a patient with this essential
thrombocythaemia has received unnecessary
treatment potentially resulting in iatrogenically
life-threatening hypokalaemia. Despite this, the
case report importantly highlights the persisting
poor awareness of this phenomenon among
healthcare professionals.
18 The article has elabo-
rated on this phenomenon and has discussed the
aetiology and underlying principles of spurious
hyperkalaemia. A plasma potassium levels
should be recorded in these patients to provide
true potassium levels.
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